Ovidac (HCG) Information

Ovidac (HCG) Information  
HCG is a hormone that is naturally produced by the female placenta during normal pregnancy. This medicine’s action is highly similar to luteinizing hormone (LH), because this hormone is known to be able to cause ovulation. If it is combined with other medicines and drugs, Ovidac (HCG) is highly effective in helping female patients become pregnant. This drug can also help males patients that are suffering from fertility issues (a treatment with this medicine usually enables such cases to produce a higher amount of testosterone).

Ovidac HCG Injection | Ovidac 5000 iu | Fast Escrow Refills
Ovidac(HCG) is a popular medicine that is regularly prescribed to female patients as part of a regimen that is supposed to induce:



Ovulation induction in subfertility that is usually triggered by impaired follicle-ripening or by anovulation. - Luteal phase support.

Follicle preparation for puncture in controlled ovarian hyperstimulation programs (this usually occurs in the case of medically assisted reproductive methods and techniques).
Ovidac(HCG) is a medicine that is regularly prescribed to male patients because of its ability to induce





Ovidac(HCG) Indications

Ovidac(HCG) is a popular medicine that helps both male and female patients deal with infertility. However, this medicine can also be used for some other purposes (to treat or to prevent some other medical conditions) that have not been listed here.

Ovidac(HCG) Warnings
In the case of female patients who want to be treated with Ovidac (HCG):
Since infertile female patients who undergo medically assisted reproduction (especially those who need in vitro fertilization), are known to often be suffering from tubal abnormalities, after treatment with this drug they might experience much more ectopic pregnancies. This is why early ultrasound confirmation at the beginning of a pregnancy (to see whether the pregnancy is intrauterine or not) is crucial. - Pregnancies who have occurred after treatment with this medicine are submitted to a higher risk of multiplets. - Female patients who have thrombosis, severe obesity or thrombophilia should not be prescribed this medicine as they have a higher risk of arterial or venous thromboembolic events after or during treatment with Ovidac (HCG).

Female patients who have been treated with this medicine are usually more prone to pregnancy losses.

In the case of male patients: A prolonged treatment with Ovidac (HCG) is known to regularly lead to increased production of androgen. Therefore:

Patients who are suffering from overt or latent cardiac failure, hypertension, renal dysfunction, migraine or Epilepsy might not be allowed to start using this medicine or might have to be prescribed a lower dose of Ovidac (HCG). - This medicine should be used with extreme cautious in the case of prepubertal teenagers in order to reduce the risk of experiencing precocious sexual development or premature epiphyseal closure. This type of patients’ skeletal maturation should be closely and regularly monitored.

Both male and female patients who have the following medical conditions must not start a treatment with Ovidac (HCG): - Hypersensitivity to this medicine or to any of its main ingredients. - Known or possible androgen-dependent tumors, for example, male breast carcinoma or prostatic carcinoma.

Previous
Next Post »